★ Plus de 150 structures
et experts déjà en ligne
Established over 100 years ago and part of the Centre for Materials Engineering Research (CRIM) as well as the MATERIAUX Institute, the Department of Metallurgy at UMONS boasts recognised expertise in all things metal-related: ferrous and non-ferrous alloys found in a wide range of sectors, from steelmaking to battery recycling using chemical technologies.
An interview with Mrs Rose Detaille, Managing Director of ISSeP: find out more about ISSeP’s four key areas of expertise, its major European partnerships, examples of ongoing R&D projects with international partners and research projects funded from its own resources as well as its contribution to Wallonia’s social, economic and ecological transition. ISSeP: a cornerstone of the transition in Wallonia, transforming knowledge into a catalyst for action. 🌳🍃💧
At the interface of photochemistry and photophysics, the research group studies the physical and chemical processes that occur when a chromophore absorbs light. Its work combines a fundamental approach with practical applications. 💥⚡
Community research: an integrative and participatory vision of health, a reversal of the clinician/patient relationship, academics and non-academics on an equal footing, and the will to restore empowerment to vulnerable users. 🩺👩⚕️
In 2025, the Belgium-based biotechnology start-up Perseus Biomics introduced DynaMAP (Dynamic Microbiome Abundance Profiling), a metagenomic technology platform designed to deliver high-resolution microbiome analysis. In the same year, the company also launched MetaMAP, an integrated benchtop device that enables DynaMAP customers to perform analyses within their own laboratories. 🧪
Electrochemical processes should be applied on a large scale to reduce our carbon footprint and chemical consumption. That is the guiding principle of Noah Water Solutions. The company has already developed a basic process for wastewater purification and a reactor for industrial use. At present, it is fine-tuning nitrogen removal and developing applications for smaller-scale use. 💧
With 2000 scientists in Belgium and a total of 9.000 employees, 19 candidate vaccines in the pipeline and 1.5 billion € of R&D expenditure in 2023, GSK is the largest pharma company in Belgium. An interview with Phd Jamila Louahed, Vice President, Head of Therapeutic Vaccines R&D and the Rixensart R&D center at GSK. 💊
